Skip to main content
Top
Published in: Critical Care 6/2008

01-12-2008 | Review

Bench-to-bedside review: Bacterial virulence and subversion of host defences

Authors: Steven AR Webb, Charlene M Kahler

Published in: Critical Care | Issue 6/2008

Login to get access

Abstract

Bacterial pathogens possess an array of specific mechanisms that confer virulence and the capacity to avoid host defence mechanisms. Mechanisms of virulence are often mediated by the subversion of normal aspects of host biology. In this way the pathogen modifies host function so as to promote the pathogen's survival or proliferation. Such subversion is often mediated by the specific interaction of bacterial effector molecules with host encoded proteins and other molecules. The importance of these mechanisms for bacterial pathogens that cause infections leading to severe community-acquired infections is well established. In contrast, the importance of specialised mechanisms of virulence in the genesis of nosocomial bacterial infections, which occur in the context of local or systemic defects in host immune defences, is less well established. Specific mechanisms of bacterial resistance to host immunity might represent targets for therapeutic intervention. The clinical utility of such an approach for either prevention or treatment of bacterial infection, however, has not been determined.
Literature
1.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34: 1589-1596. 10.1097/01.CCM.0000217961.75225.E9CrossRefPubMed Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34: 1589-1596. 10.1097/01.CCM.0000217961.75225.E9CrossRefPubMed
2.
go back to reference Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J: Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004, 30: 589-596. 10.1007/s00134-004-2157-0CrossRefPubMed Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J: Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004, 30: 589-596. 10.1007/s00134-004-2157-0CrossRefPubMed
3.
go back to reference Vandenbroucke-Grauls CM, Vandenbroucke JP: Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991, 338: 859-862. 10.1016/0140-6736(91)91510-2CrossRefPubMed Vandenbroucke-Grauls CM, Vandenbroucke JP: Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991, 338: 859-862. 10.1016/0140-6736(91)91510-2CrossRefPubMed
4.
go back to reference Lim SM, Webb SA: Nosocomial bacterial infections in intensive care units. I: organisms and mechanisms of antibiotic resistance. Anaesthesia 2005, 60: 887-902. 10.1111/j.1365-2044.2005.04220.xCrossRefPubMed Lim SM, Webb SA: Nosocomial bacterial infections in intensive care units. I: organisms and mechanisms of antibiotic resistance. Anaesthesia 2005, 60: 887-902. 10.1111/j.1365-2044.2005.04220.xCrossRefPubMed
5.
go back to reference Overbye KM, Barrett JF: Antibiotics: where did we go wrong? Drug Discov Today 2005, 10: 45-52. 10.1016/S1359-6446(04)03285-4CrossRefPubMed Overbye KM, Barrett JF: Antibiotics: where did we go wrong? Drug Discov Today 2005, 10: 45-52. 10.1016/S1359-6446(04)03285-4CrossRefPubMed
6.
go back to reference Falkow S: What is a pathogen? Am Soc Microbiol News 1991, 63: 356-359. Falkow S: What is a pathogen? Am Soc Microbiol News 1991, 63: 356-359.
7.
8.
go back to reference Falkow S: The evolution of pathogenicity. In Escherichia coli and Salmonella cellular and molecular biology. Edited by: Neidhardt FC. Washington, DC: ASM Press; 1996. Falkow S: The evolution of pathogenicity. In Escherichia coli and Salmonella cellular and molecular biology. Edited by: Neidhardt FC. Washington, DC: ASM Press; 1996.
9.
go back to reference Kooi TI, de Boer AS, Mannien J, Wille JC, Beaumont MT, Mooi BW, Hof S: Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med 2007, 33: 271-278. 10.1007/s00134-006-0464-3CrossRefPubMed Kooi TI, de Boer AS, Mannien J, Wille JC, Beaumont MT, Mooi BW, Hof S: Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med 2007, 33: 271-278. 10.1007/s00134-006-0464-3CrossRefPubMed
10.
go back to reference Wolkewitz M, Vonberg RP, Grundmann H, Beyersmann J, Gastmeier P, Barwolff S, Geffers C, Behnke M, Ruden H, Schumacher M: Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008, 12: R44. 10.1186/cc6852PubMedCentralCrossRefPubMed Wolkewitz M, Vonberg RP, Grundmann H, Beyersmann J, Gastmeier P, Barwolff S, Geffers C, Behnke M, Ruden H, Schumacher M: Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008, 12: R44. 10.1186/cc6852PubMedCentralCrossRefPubMed
11.
go back to reference Papazian L, Bregeon F, Thirion X, Gregoire R, Saux P, Denis JP, Perin G, Charrel J, Dumon JF, Affray JP, Gouin F: Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996, 154: 91-97.CrossRefPubMed Papazian L, Bregeon F, Thirion X, Gregoire R, Saux P, Denis JP, Perin G, Charrel J, Dumon JF, Affray JP, Gouin F: Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996, 154: 91-97.CrossRefPubMed
12.
go back to reference Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999, 159: 1249-1256.CrossRefPubMed Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999, 159: 1249-1256.CrossRefPubMed
13.
go back to reference Falkow S: Molecular Koch's postulates applied to bacterial pathogenicity – a personal recollection 15 years later. Nat Rev Microbiol 2004, 2: 67-72. 10.1038/nrmicro799CrossRefPubMed Falkow S: Molecular Koch's postulates applied to bacterial pathogenicity – a personal recollection 15 years later. Nat Rev Microbiol 2004, 2: 67-72. 10.1038/nrmicro799CrossRefPubMed
14.
go back to reference Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H: Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 1997, 23: 1089-1097. 10.1046/j.1365-2958.1997.3101672.xCrossRefPubMed Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H: Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 1997, 23: 1089-1097. 10.1046/j.1365-2958.1997.3101672.xCrossRefPubMed
15.
go back to reference Mahan MJ, Heithoff DM, Sinsheimer RL, Low DA: Assesment of bacterial pathogenesis by analysis of gene expression in the host. Annu Rev Genet 2000, 34: 139-164. 10.1146/annurev.genet.34.1.139CrossRefPubMed Mahan MJ, Heithoff DM, Sinsheimer RL, Low DA: Assesment of bacterial pathogenesis by analysis of gene expression in the host. Annu Rev Genet 2000, 34: 139-164. 10.1146/annurev.genet.34.1.139CrossRefPubMed
16.
go back to reference Hornef MW, Wick MJ, Rhen M, Normark S: Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 2002, 3: 1033-1040. 10.1038/ni1102-1033CrossRefPubMed Hornef MW, Wick MJ, Rhen M, Normark S: Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 2002, 3: 1033-1040. 10.1038/ni1102-1033CrossRefPubMed
17.
18.
go back to reference Scott JR, Zahner D: Pili with strong attachments: Gram-positive bacteria do it differently. Mol Microbiol 2006, 62: 320-330. 10.1111/j.1365-2958.2006.05279.xCrossRefPubMed Scott JR, Zahner D: Pili with strong attachments: Gram-positive bacteria do it differently. Mol Microbiol 2006, 62: 320-330. 10.1111/j.1365-2958.2006.05279.xCrossRefPubMed
19.
go back to reference Sansonetti PJ, Phalipon A: M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin Immunol 1999, 11: 193-203. 10.1006/smim.1999.0175CrossRefPubMed Sansonetti PJ, Phalipon A: M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin Immunol 1999, 11: 193-203. 10.1006/smim.1999.0175CrossRefPubMed
20.
go back to reference Friebel A, Ilchmann H, Aepfelbacher M, Ehrbar K, Machleidt W, Hardt WD: SopE and SopE2 from Salmonella typhimurium activate different sets of RhoGTPases of the host cell. J Biol Chem 2001, 276: 34035-34040. 10.1074/jbc.M100609200CrossRefPubMed Friebel A, Ilchmann H, Aepfelbacher M, Ehrbar K, Machleidt W, Hardt WD: SopE and SopE2 from Salmonella typhimurium activate different sets of RhoGTPases of the host cell. J Biol Chem 2001, 276: 34035-34040. 10.1074/jbc.M100609200CrossRefPubMed
21.
go back to reference Meresse S, Steele-Mortimer O, Moreno E, Desjardins M, Finlay B, Gorvel JP: Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat Cell Biol 1999, 1: E183-E188. 10.1038/15620CrossRefPubMed Meresse S, Steele-Mortimer O, Moreno E, Desjardins M, Finlay B, Gorvel JP: Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat Cell Biol 1999, 1: E183-E188. 10.1038/15620CrossRefPubMed
22.
go back to reference Bruggemann H, Cazalet C, Buchrieser C: Adaptation of Legionella pneumophila to the host environment: role of protein secretion, effectors and eukaryotic-like proteins. Curr Opin Microbiol 2006, 9: 86-94. 10.1016/j.mib.2005.12.009CrossRefPubMed Bruggemann H, Cazalet C, Buchrieser C: Adaptation of Legionella pneumophila to the host environment: role of protein secretion, effectors and eukaryotic-like proteins. Curr Opin Microbiol 2006, 9: 86-94. 10.1016/j.mib.2005.12.009CrossRefPubMed
23.
go back to reference Nagai H, Kagan JC, Zhu X, Kahn RA, Roy CR: A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science 2002, 295: 679-682. 10.1126/science.1067025CrossRefPubMed Nagai H, Kagan JC, Zhu X, Kahn RA, Roy CR: A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science 2002, 295: 679-682. 10.1126/science.1067025CrossRefPubMed
24.
go back to reference Kagan JC, Stein MP, Pypaert M, Roy CR: Legionella subvert the functions of Rab1 and Sec22b to create a replicative organelle. J Exp Med 2004, 199: 1201-1211. 10.1084/jem.20031706PubMedCentralCrossRefPubMed Kagan JC, Stein MP, Pypaert M, Roy CR: Legionella subvert the functions of Rab1 and Sec22b to create a replicative organelle. J Exp Med 2004, 199: 1201-1211. 10.1084/jem.20031706PubMedCentralCrossRefPubMed
25.
go back to reference Rosenberger CM, Finlay BB: Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat Rev Mol Cell Biol 2003, 4: 385-396. 10.1038/nrm1104CrossRefPubMed Rosenberger CM, Finlay BB: Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat Rev Mol Cell Biol 2003, 4: 385-396. 10.1038/nrm1104CrossRefPubMed
26.
go back to reference Persson C, Carballeira N, Wolf-Watz H, Fallman M: The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. Embo J 1997, 16: 2307-2318. 10.1093/emboj/16.9.2307PubMedCentralCrossRefPubMed Persson C, Carballeira N, Wolf-Watz H, Fallman M: The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. Embo J 1997, 16: 2307-2318. 10.1093/emboj/16.9.2307PubMedCentralCrossRefPubMed
27.
go back to reference Knodler LA, Celli J, Finlay BB: Pathogenic trickery: deception of host cell processes. Nat Rev Mol Cell Biol 2001, 2: 578-588. 10.1038/35085062CrossRefPubMed Knodler LA, Celli J, Finlay BB: Pathogenic trickery: deception of host cell processes. Nat Rev Mol Cell Biol 2001, 2: 578-588. 10.1038/35085062CrossRefPubMed
28.
go back to reference Goehring UM, Schmidt G, Pederson KJ, Aktories K, Barbieri JT: The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem 1999, 274: 36369-36372. 10.1074/jbc.274.51.36369CrossRefPubMed Goehring UM, Schmidt G, Pederson KJ, Aktories K, Barbieri JT: The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem 1999, 274: 36369-36372. 10.1074/jbc.274.51.36369CrossRefPubMed
29.
go back to reference Merrell DS, Falkow S: Frontal and stealth attack strategies in microbial pathogenesis. Nature 2004, 430: 250-256. 10.1038/nature02760CrossRefPubMed Merrell DS, Falkow S: Frontal and stealth attack strategies in microbial pathogenesis. Nature 2004, 430: 250-256. 10.1038/nature02760CrossRefPubMed
30.
go back to reference Lau GW, Hassett DJ, Britigan BE: Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol 2005, 13: 389-397. 10.1016/j.tim.2005.05.011CrossRefPubMed Lau GW, Hassett DJ, Britigan BE: Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol 2005, 13: 389-397. 10.1016/j.tim.2005.05.011CrossRefPubMed
31.
go back to reference Marriott HM, Dockrell DH: Streptococcus pneumoniae : the role of apoptosis in host defense and pathogenesis. Int J Biochem Cell Biol 2006, 38: 1848-1854. 10.1016/j.biocel.2006.06.001CrossRefPubMed Marriott HM, Dockrell DH: Streptococcus pneumoniae : the role of apoptosis in host defense and pathogenesis. Int J Biochem Cell Biol 2006, 38: 1848-1854. 10.1016/j.biocel.2006.06.001CrossRefPubMed
32.
go back to reference Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, Banerjee S, Flavell RA, Yuan J, Sansonetti PJ, Zychlinsky A: Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J Biol Chem 1998, 273: 32895-32900. 10.1074/jbc.273.49.32895CrossRefPubMed Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, Banerjee S, Flavell RA, Yuan J, Sansonetti PJ, Zychlinsky A: Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J Biol Chem 1998, 273: 32895-32900. 10.1074/jbc.273.49.32895CrossRefPubMed
33.
go back to reference Kraiczy P, Wurzner R: Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol 2006, 43: 31-44. 10.1016/j.molimm.2005.06.016CrossRefPubMed Kraiczy P, Wurzner R: Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol 2006, 43: 31-44. 10.1016/j.molimm.2005.06.016CrossRefPubMed
34.
go back to reference Schneider MC, Exley RM, Ram S, Sim RB, Tang CM: Interactions between Neisseria meningitidis and the complement system. Trends Microbiol 2007, 15: 233-240. 10.1016/j.tim.2007.03.005CrossRefPubMed Schneider MC, Exley RM, Ram S, Sim RB, Tang CM: Interactions between Neisseria meningitidis and the complement system. Trends Microbiol 2007, 15: 233-240. 10.1016/j.tim.2007.03.005CrossRefPubMed
35.
go back to reference Jarva H, Jokiranta TS, Wurzner R, Meri S: Complement resistance mechanisms of streptococci. Mol Immunol 2003, 40: 95-107. 10.1016/S0161-5890(03)00108-1CrossRefPubMed Jarva H, Jokiranta TS, Wurzner R, Meri S: Complement resistance mechanisms of streptococci. Mol Immunol 2003, 40: 95-107. 10.1016/S0161-5890(03)00108-1CrossRefPubMed
36.
go back to reference Smith RS, Iglewski BH: P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 2003, 6: 56-60. 10.1016/S1369-5274(03)00008-0CrossRefPubMed Smith RS, Iglewski BH: P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 2003, 6: 56-60. 10.1016/S1369-5274(03)00008-0CrossRefPubMed
37.
go back to reference Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN: Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect Immun 1999, 67: 5854-5862.PubMedCentralPubMed Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN: Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect Immun 1999, 67: 5854-5862.PubMedCentralPubMed
38.
go back to reference Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003, 112: 1466-1477.PubMedCentralCrossRefPubMed Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003, 112: 1466-1477.PubMedCentralCrossRefPubMed
39.
go back to reference Drenkard E: Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 2003, 5: 1213-1219. 10.1016/j.micinf.2003.08.009CrossRefPubMed Drenkard E: Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 2003, 5: 1213-1219. 10.1016/j.micinf.2003.08.009CrossRefPubMed
40.
go back to reference Strauss E: Microbiology. Simple hosts may help reveal how bacteria infect cells. Science 2000, 290: 2245-2247. 10.1126/science.290.5500.2245CrossRefPubMed Strauss E: Microbiology. Simple hosts may help reveal how bacteria infect cells. Science 2000, 290: 2245-2247. 10.1126/science.290.5500.2245CrossRefPubMed
41.
go back to reference Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ: Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 2005, 310: 670-674. 10.1126/science.1116739CrossRefPubMed Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ: Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 2005, 310: 670-674. 10.1126/science.1116739CrossRefPubMed
42.
go back to reference Otto M: Quorum-sensing control in Staphylococci – a target for antimicrobial drug therapy? FEMS Microbiol Lett 2004, 241: 135-141. 10.1016/j.femsle.2004.11.016CrossRefPubMed Otto M: Quorum-sensing control in Staphylococci – a target for antimicrobial drug therapy? FEMS Microbiol Lett 2004, 241: 135-141. 10.1016/j.femsle.2004.11.016CrossRefPubMed
43.
go back to reference Valle J, Da Re S, Henry N, Fontaine T, Balestrino D, Latour-Lambert P, Ghigo JM: Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide. Proc Natl Acad Sci USA 2006, 103: 12558-12563. 10.1073/pnas.0605399103PubMedCentralCrossRefPubMed Valle J, Da Re S, Henry N, Fontaine T, Balestrino D, Latour-Lambert P, Ghigo JM: Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide. Proc Natl Acad Sci USA 2006, 103: 12558-12563. 10.1073/pnas.0605399103PubMedCentralCrossRefPubMed
Metadata
Title
Bench-to-bedside review: Bacterial virulence and subversion of host defences
Authors
Steven AR Webb
Charlene M Kahler
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2008
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc7091

Other articles of this Issue 6/2008

Critical Care 6/2008 Go to the issue